S. Richman

发表

Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.

S. Albelda, E. Moon, Liang-chuan Wang, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design

J. Rabinowitz, C. June, J. C. García-Cañaveras, 2020, Molecular therapy. Methods & clinical development.

Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.

P. Allen, P. Greenberg, D. Kranz, 2009, Molecular Immunology.

β‐synuclein at the “synapse” of encephalitis and neurodegeneration in multiple sclerosis?

C. Hunter, S. Richman, 2019, Immunology and cell biology.

Biosensor detection systems: engineering stable, high-affinity bioreceptors by yeast surface display.

D. Kranz, J. Stone, S. Richman, 2009, Methods in molecular biology.

Guideline for Children With Cancer Receiving General Anesthesia for Procedures and Imaging

Michael Fisher, J. Minturn, R. Bagatell, 2022, Journal of pediatric hematology/oncology.

High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model

Z. Mourelatos, S. Grupp, D. Barrett, 2017, Cancer Immunology Research.

Development of a novel strategy for engineering high-affinity proteins by yeast display.

P. Allen, P. Greenberg, D. Kranz, 2006, Protein engineering, design & selection : PEDS.

Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD

J. Emond, M. Sykes, T. Kato, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains

Thomas M. Schmitt, B. Baker, P. Greenberg, 2011, Gene Therapy.

Display, engineering, and applications of antigen-specific T cell receptors.

David M Kranz, D. Kranz, Sarah A Richman, 2007, Biomolecular engineering.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Imaging CAR T Cell Trafficking with eDFHR as a PET Reporter Gene.

R. Mach, C. Hou, M. Milone, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments.

P. Allen, P. Greenberg, D. Kranz, 2009, Molecular immunology.

Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.

Thomas M. Schmitt, P. Greenberg, D. Kranz, 2013, Blood.

Neurotoxicity Associated with a High-Affinity GD2 CAR—Response

M. Milone, S. Richman, 2018, Cancer Immunology Research.

In vivo monitoring of CAR T cells using [18F]fluoropropyl-trimethoprim

D. Mankoff, R. Mach, C. Hou, 2018 .

Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.

S. Albelda, E. Moon, M. Milone, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.